MERRIMACK PHARMACEUTICALS - ASSETS
Merrimack Pharmaceuticals - Assets (irinotecan liposome injection) for the treatment of patients with metastatic adenocarcinoma of pancreas.
MERRIMACK PHARMACEUTICALS - ASSETS
Industry:
Biotechnology
Address:
Cambridge, Massachusetts, United States
Country:
United States
Status:
Active